Publications – Page 3 – KalVista Pharmaceuticals

Showing 21-30 out of 36

Characterizing the Negative Impact of Delayed On-Demand Treatment of HAE Attacks (#284)

Princess Ogbogu, Hilary Longhurst, Sally van Kooten, Neil Malloy, Markus Heckmann, Julie Ulloa, Ricardo Zwiener

Anxiety Associated with Refilling On-demand Therapy for HAE Attacks Contributes to Treatment Delay and Non-Treatment (#258)

Daniel F. Soteres, Anete S. Grumach, Sally van Kooten, Neil Malloy, Markus Heckmann, Julie Ulloa, Autumn Burnette

Anxiety Associated with On-Demand Treatment for Hereditary Angioedema (HAE) Attacks (#257)

James Wedner, Cristine Radojicic, Julie Ulloa, Sherry Danese, Vibha Desai, Shawn Czado, Paul Audhya, Sandra Christiansen

Delayed On-demand Treatment of Hereditary Angioedema Attacks: Patient Perceptions and Associated Barriers (#270)

Sandra Christiansen, Maeve O’Connor, Julie Ulloa, Sherry Danese, Vibha Desai, Shawn Czado, Paul Audhya, Paula Busse

Characteristics of Hereditary Angioedema Attacks Among Long-Term Prophylaxis Users (#215)

Bob Geng, Vibha Desai, Julie Ulloa, Sherry Danese, Shawn Czado, Paul Audhya, Timothy Craig

Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks

Tachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK

Understanding Why Hereditary Angioedema Patients Often Do Not Carry Their On-Demand Treatment with Them

Geng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C

Anxiety Associated with On-Demand Treatment of HAE Attacks May Result in Suboptimal Attack Management

Manning M, van Kooten S, Heckmann M, Danese S, Goga L, Ogbogu PU

In Their Own Words – Patient Descriptions of the Earliest Recognition of HAE Attack Onset

Manning ME, Burnette AF, van Kooten S, Heckmann M, Danese S, Goga L, Guilarte M

Recognizing the Importance of Early On-Demand Treatment in the HAE Attack Journey

Jones DH, Ogbogu P, van Kooten S, Heckmann M, Danese S, Goga L, Magerl M

About